Latest news

Nanologica has made the first delivery of the company’s non-silica-based purification media NLAB Siv™ to a customer in Asia against an order received in November. The value amounts to over MSEK 4. NLAB Siv™ is a non-silica-based purification media that has been developed together with a customer who sells a number of pharmaceutical products. NLAB Siv™ is used for purification through preparative chromatography and the customer has expressed a desire to replace the purification media

FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 75 (674) and for the full year to TSEK 1,443 (1,555) The operating loss for the quarter amounted to TSEK -35,638 (-13,251) and for the full year to TSEK -69,963 (-50,850). Operating loss was affected by write-downs of tangible and intangible assets during the quarter as well as for the full year totaling TSEK 14,523 (0) Loss after tax for the quarter amounted to

Nanologica’s Chinese distributor Yunbo Technologies has made a first call-off against the agreement previously signed for the delivery of silica worth USD 14 million over a six-year period. In connection with Nanologica’s start of large-scale production of silica in 2019, a supply agreement was signed with the company’s Chinese distributor Yunbo Technologies, whereby Nanologica will deliver media for preparative chromatography to a value of approximately USD 14 million over a six-year period. The delivery that